
Media Coverage
General Inquiries:
info@immuneregen.com
Media Coverage:
Amendola Communications
Jan Shulman
Executive Vice President
480.664.8412, ext. 12
JShulman@acmarketingpr.com
Investor Relations:
Tony Schor or Lindsay Kenoe
Investor Awareness, Inc.
847-945-2222
www.investorawareness.com
investors@immuneregen.com
Copyright © 2003-2008, ImmuneRegen Biosciences, Inc.
All rights reserved.